BAFNA PHARMACEUTICALS LTD (BAFNAPH)

NSE: ₹160.31
BSE: ₹162.50
Back to Home
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 42.24 41.95 40.68 28.44 41.40 33.29 40.32 33.19 39.06 34.62 35.47 38.29
YOY Revenue Growth % 181.96% 147.81% 85.23% -16.88% -2% -20.65% -0.87% 16.68% -5.65% 4.02% -12.04% 15.36%
Other Income 0.26 1.87 0.16 0.98 0.52 0.51 1.02 0.19 1.03 0.60 1.18 1.22
Total Income 42.50 43.82 40.84 29.42 41.91 33.79 41.35 33.38 40.09 35.22 36.65 39.51
Total Expenses + 30.33 32.53 32.83 28.04 40.24 30.60 36.56 29.25 36.99 31.83 33.52 37.67
Cost of Materials Consumed 19.72 19.56 19.67 16.00 23.79 18.37 21.82 16.87 17.43 17.56 18.56 24.00
Employee Benefit Expense 4.57 4.27 4.85 4.53 5.38 5.14 5.06 5.26 5.58 5.64 5.49 5.35
Other Expenses 6.03 8.69 8.32 7.52 11.07 7.10 9.68 7.12 8.82 6.58 7.63 7.68
Operating Profit 11.92 9.42 7.85 0.40 1.16 2.69 3.76 3.94 2.07 2.79 1.95 0.62
OPM % 28.2% 22.5% 19.3% 1.4% 2.8% 8.1% 9.3% 11.9% 5.3% 8.1% 5.5% 1.6%
Profit Before Tax + 5.65 6.35 2.48 -2.94 1.46 -0.72 2.62 0.95 1.31 3.39 3.12 1.84
Tax Expense 0.28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax % 4.9% 0% 0% - 0% - 0% 0% 0% 0% 0% 0%
Profit After Tax 5.37 6.35 2.48 -2.94 1.46 -0.72 2.62 0.95 1.31 3.39 3.12 1.84
EPS (Basic) 2.34 2.68 1.05 -1.24 0.62 -0.31 1.11 0.40 0.55 1.43 1.32 0.78

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 145.86 152.47 115.35 85.14 71.22 42.47
YOY Revenue Growth % -4.33% 32.18% 35.48% 19.55% 67.68% -
Other Income 2.74 3.52 3.27 2.10 0.75 0.26
Total Income 148.60 155.99 118.62 87.24 71.97 42.73
Total Expenses + 142.30 133.64 96.14 75.42 57.97 44.46
Cost of Materials Consumed 74.49 79.01 59.57 53.06 42.51 30.24
Employee Benefit Expense 21.03 19.03 15.87 14.50 11.98 10.25
Other Expenses 32.72 35.60 20.70 7.86 3.48 3.97
Operating Profit 3.56 18.83 19.21 9.72 13.24 -1.99
OPM % 2.4% 12.3% 16.7% 11.4% 18.6% -4.7%
Profit Before Exceptional 6.30 7.35 11.62 7.31 5.83 -1.88
Exceptional Items -2.15 0.00 0.00 -2.16 0.00 -23.33
Profit Before Tax + 4.15 7.35 11.62 5.15 5.83 -25.20
Tax Expense 0.00 0.00 0.28 0.00 0.00 0.00
Tax % 0% 0% 2.4% 0% 0% -
Profit After Tax 4.15 7.35 11.34 5.15 5.83 -25.20
EPS (Basic) 1.76 3.11 4.86 4.34 2.46 -106.54

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 66.90 53.21 42.27 0.00 0.00 0.00
Property, Plant & Equipment 58.78 40.21 40.23 0.00 0.00 0.00
Capital Work in Progress 7.31 10.50 1.50 0.00 0.00 0.00
Non-Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 84.73 94.47 87.31 0.00 0.00 0.00
Inventories 28.09 29.64 22.22 0.00 0.00 0.00
Trade Receivables 40.17 45.39 41.15 0.00 0.00 0.00
Cash and Cash Equivalents 3.43 1.40 7.81 0.00 0.00 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 23.66 23.66 23.66 0.00 0.00 0.00
Other Equity 61.15 57.18 49.80 0.00 0.00 0.00
Non-Current Liabilities 16.42 12.76 9.65 0.00 0.00 0.00
Current Liabilities 51.85 54.08 46.48 0.00 0.00 0.00
Total Liabilities 68.27 66.84 56.13 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 22.14 9.48 4.95 6.53 0.00 0.00
Cash from Investing Activities -21.16 -15.05 -7.49 -4.54 0.00 0.00
Cash from Financing Activities 1.06 -0.85 10.18 -3.62 0.00 0.00
Net Increase/Decrease in Cash 2.04 -6.41 7.64 -1.63 0.00 0.00